跳至主要内容
临床试验/NCT05074160
NCT05074160进行中(未招募)不适用

OCS Liver Perfusion (OLP) Post-Approval Registry

TransMedics9 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2021年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
TransMedics
入组人数
166
试验地点
9
主要终点
Patient Survival

研究概览

简要总结

The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.

详细描述

OLP Registry is a multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult primary liver transplant recipients of DBD or DCD donor Livers perfused on OCS Liver System

排除标准

  • Donor livers with accessory arterial blood supply requiring back table anastomosis, major traumatic injury, or hematoma; or
  • Split donor liver; or
  • DCD donor liver with >30 minutes of warm ischemic time (defined as from withdrawal of life support until donor liver cold flush); or
  • DCD donors age >55 years; or
  • DCD donor liver with macrosteatosis of >15%
  • Living donors
  • Donors with positive serology for HIV, Hep B and C
  • Donors with macrosteatosis of ≥40%
  • Recipient Exclusion Criteria:
  • Fulminant liver failure; or
  • Concurrent (multi-organ transplant) or previous solid organ or bone marrow transplant; or
  • Chronic renal dialysis at time of transplant; or
  • Dependency on more than 1 inotropic agent to maintain hemodynamics; or
  • Ventilator dependent at time of transplant.

结局指标

主要结局

Patient Survival

时间窗: 1 year post-Liver transplant

1-year patient survival with the originally transplanted liver (patient and graft survival) post-Liver transplant.

次要结局

未报告次要终点

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

OCS Liver Perfusion (OLP) Post-Approval Registry | 临床试验